Cargando…
Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
SIMPLE SUMMARY: Prostate cancer treatment decisions are based on clinical stage and histological diagnosis, including Gleason grading assessed by a pathologist, in biopsies. Prior to staging and grading, serum or blood prostate-specific antigen (PSA) levels are measured and often trigger diagnostic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914622/ https://www.ncbi.nlm.nih.gov/pubmed/33562508 http://dx.doi.org/10.3390/cancers13040628 |